No. AR PL HD Year Citation Title 1st author
88 X 2021 Sci Rep 11(1):11472(2021) Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey M Shimamura
87 X X 2021 Acute Med Surg 8(1):e648(2021) Influence of high‐dose antithrombin on platelet function and blood coagulation T Miike
86 X 2021 J Functional Foods 80, 104438(2021) Anti-platelet activity of phytocompounds in various dandelion organs in human whole blood model in vitro B Lis
85 X 2021 Int J Mol Sci 22(6):3282(2021) Anti-Platelet Properties of Phenolic and Nonpolar Fractions Isolated from Various Organs of Elaeagnus rhamnoides (L.) A. Nelson in Whole Blood B Skalski
84 X 2021 J Clin Med 10(5):1024 (2021) Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension A Gąsecka
83 X X 2021 Platelets. Apr 15:1-6 (2021) Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison CR Clifford
82 X 2021 Biomed Pharmacother 137, 111395(2021) Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson M Juszczak
81 X X 2021 Thromb Res 200,p141-148(2021) Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention N Nakanishi
80 X X 2021 J Vet Diagn Invest Analysis of blood clotting with the total thrombus analysis system in healthy dogs T Iwanaga
79 X 2021 Platelets 1-5(2021) The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions KL Zheng
78 X 2021 Thromb Haemost Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study S Ghirardello
77 X 2020 Molecules 25(22):5402(2020) Flavonoid Preparations from Taraxacum officinale L. Fruits-A Phytochemical, Antioxidant and Hemostasis Studies B Lis
76 X 2020 Undersea Hyperb Med 47(4),p591-595(2020) Influence of hyperbaric oxygen therapy on thrombus formation ability in humans T Miike
75 X 2020 Blood Adv 4 (21): 5501-5511(2020) Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system Y Suzuki
74 X 2020 Thromb J 18,31(2020) A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia B Atari
73 X 2020 Int J Cardiol S0167-5273(20),p33924-33933(2020) Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention N Nakanishi
72 X X 2020 Pol Arch Intern Med 130(12),p1114-1117(2020) Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome? K Ożegowska
71 X 2020 J Clin Med 9(8):2636(2020) Advances in Platelet Function Testing-Light Transmission Aggregometry and Beyond JL Blanc
70 X 2020 PLoS ONE 15(10): e0237843(2020) Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus M Osiński
69 X X 2020 Pediatr Int (2020) A microchip flow-chamber assay screens congenital primary hemostasis disorders Y Nakajima
68 X 2020 Thromb Res 194,p98-100(2020) Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit A Ågren
67 X X 2020 Kardiol Pol 78(7-8),p667-673(2020) New methodological approaches for assessing thrombus formation in cardiovascular disease K Hosokawa
66 X 2020 J Pediatr S0022-3476(20),p30726-30735(2020) Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease N Tsujii
65 X 2020 Br J Haematol 191(1), e7-e10(2020) Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System in Comparison to the Platelet Function Analyser in Subjects With Primary Haemostatic Defects J Charpy
64 X 2020 Int J Mol Sci 21(11),3972(2020) E8002 Inhibits Peripheral Nerve Adhesion by Enhancing Fibrinolysis of l-Ascorbic Acid in a Rat Sciatic Nerve Model K Kikuchi
63 X X 2020 ESC Heart Fail 7(5),p3235-3239(2020) Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system S Takashio
62 X X 2020 Front Vet Sci 7:307(2020) A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis T Iwanaga
61 X 2020 In Vivo 34(4),p1871-1874(2020) Association Between HMGB1 and Thrombogenesis in a Hyperlipaemia-induced Microminipig Model of Atherosclerosis S Kase
60 X X 2020 Circ J 84(6),p975-984(2020) Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention S Kikuchi
59 X 2019 Haematologica 235549(2019) Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab K Sakai
58 X X 2019 Int J Hematol 111, p369-377(2020) Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system Y Nakajima
57 X X 2019 J Atheroscler Thromb 27(3),p201-203(2020) Monitoring of Antithrombotic Therapy M Yamazaki
56 X X 2019 Thromb J 17, 17 (2019) Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study observational study K Yamamoto
55 X X 2019 J Atheroscler Thromb 27,p215-225(2020) Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease T Mitsuse
54 X X 2019 Thromb Haemost 119,p1554-1562(2019) Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease K Kaikita
53 X X 2019 Sci Rep 9:6573(2019) Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis MM Piasecka
52 X X 2019 Circ J 83(6),p1309-1316(2019) Impact of Total Antithrombotic Effect on Bleeding Complications in Patients Receiving Multiple Antithrombotic Agents S Ichikawa
51 X 2019 Int J Cardiol Heart Vasc 23:100346(2019) Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation – The ATTRACTIVE-TTAS study M Ishii
50 X X 2019 Clin Exp Thromb Hemost 5(1),p1-7(2019) Effects of Peroxisome Proliferator-Activated Receptor Ligand and Brown Seaweed Based Compound on Megakaryocyte JL Choi
49 X 2019 Front Pharmacol 10:68 (2019) Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions K Derszniak
48 X 2018 J Cardiothorac Vasc Anesth 33(8),p2125-2132(2019) Von Willebrand Factor-GP 1b α Interactions in Venoarterial Extracorporeal Membrane Oxygenation Patients M Mazzeffi
47 X 2018 Alcohol Alcohol 54(1),p13-18(2019) Inhibition by Ethanol of Shear Stress-Induced Formation of Platelet Thrombin in Whole Blood K Ekawa
46 X 2018 Sci Rep 8:15844 (2018) Uric acid enhances alteplase-mediated thrombolysis as an antioxidant K Kikuchi
45 X 2018 Blood 133(7),p633-643(2019) Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line K Tozawa
44 X X 2018 Exp Anim 68(2),p137-146,(2019) Comparison between Blood coagulability in the Intra-atrial and Peripheral Regions during the Acute Phase after Rapid Atrial Pacing S Yamada
43 X X 2018 Platelets 30(7),p893-900 (2019) Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis AR Ghaithi
42 X X 2018 Thromb Res 171,p31-37(2018) Comparison of chronological changes in blood characteristics in the atrium and peripheral vessels after the development of non-valvular atrial fibrillation S Yamada
41 X 2018 J Clin Invest 128(9),p3906-3925(2018) Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis C Klatt
40 X 2018 J Thromb Haemost 16,p1580-1591(2018) In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents R Hartmann
39 X X 2018 J Surg Res 231,p54-61(2018) Microfluidics contrasted to thrombelastography:perplexities in defining hypercoaguladility P Lawson
38 X 2018 Med Sci Sports Exerc 50(7),p1405-1412(2018) Vascular Nitric Oxide-Superoxide Balance and Thrombus Formation after Acute Exercise K Przyborowski
37 X X 2018 Blood Adv 2(6),p715-730(2018) Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction O Borst
36 X 2018 J Am Heart Assoc 7:e007694(2018) Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice GM Adamski
35 X X 2017 Blood 131(10),p1122-1144(2018) Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148 J Mori
34 X 2017 Oxid Med Cell Longev 6873281(2017) Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis K Kikuchi
33 X X 2017 Circ J 82,p524-531(2018) Edoxaban Enhances Thromboprophylaxis by Physiotherapy After Total Knee Arthroplasty - The Randomized Controlled ESCORT-TKA Trial D Sueta
32 X 2017 Sci Rep 7, 7399 (2017) Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System M Ishii
31 X X 2017 J Am Heart Assoc 6:e005263(2017) Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Y Oimatsu
30 X 2017 Thromb Res 153,p76-82(2017) Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment V Taune
29 X 2017 Haemophilia p1-9(2017) Role of red blood cells in the anemia-associated bleeding under high shear conditions H Yaoi
28 X X 2016 J Intensive Care 5:7(2017) Monitoring the coagulation status of trauma patients with viscoelastic devices Y Sakamoto
27 X 2016 J Thromb Haemost 15,p538-548(2017) Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination T Matsui
26 X X 2016 J Clin Med Res 8(12),p899-907(2016) Evaluation of the antithrombotic effects of Rivaroxaban and Apixaban using the Total Thrombus-formation Analysis System : in vitro and ex vivo studies H Sugihara
25 X 2016 Thromb Res 146,p69-75(2016) Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model K Hosokawa
24 X X 2016 Thromb Haemost 117(01),p75-85(2017) Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system A Ågren
23 X X 2016 Heart Vessels 32,p309-316(2017) Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System Y Idemoto
22 X 2016 J Thromb and Haemost 14,p1-10(2016) Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy M Yamazaki
21 X X 2016 Clin Trials Regul Sci Cardiol 19,p1-4(2016) Efficacy Study of the COmbination of Edoxaban and Physiotherapy on the PRevention of Venous-Thromboembolism in patients after Total Knee Arthroplasty (ESCORT-TKA Trial): Study protocol for a randomized controlled trial D Sueta
20 X X 2016 Haemophilia p1-8(2016) Usefulness of the Total Thrombus-formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease V Daidone
19 X 2016 Undersea Hyperb Med 43(3),p233-238(2016) Effects of hyperbaric exposure on thrombus formation T Miike
18 X X 2016 J Thromb Haemost 13,p1-8(2016) Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system K Nogami
17 X 2015 J Thromb Haemost 13,p1-10(2016) Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy Y Arima
16 X X 2015 J Am Heart Assoc 5(1):e002744 (2016) Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation M Ito
15 X X 2015 Int J Cardiol 197,p98-100(2015) A novel quantitative assessment of whole blood thrombogenicity in patients treated with a non-vitamin K oral anticoagulant D Sueta
14 X 2015 Int J Hematol 102, p157-162(2015) Use of a microchip flow-chamber system as a screening test for platelet storage pool disease. H Minami
13 X X 2014 Haemophilia 21,p71-80(2015) Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system. K Ogiwara
12 X 2013 PLoS One 9(1):e86491 (2014) Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model. K Hosokawa
11 X X 2013 J Cardiothorac Vasc Anesth 27(6),e69–e84(2013) Influences of Hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model. S Ogawa
10 X 2013 Thromb Res 133(1),p66-72,(2014) Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions. K Hosokawa
9 X 2013 Br J Anaesth 111(6),p1013-1023(2013) Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. S Ogawa
8 X X 2013 Thromb Res 132(2), p263-270 (2013) Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals. Y Yamaguchi
7 X 2013 In Vivo 27(3),p357-361(2013) Coagulation activity and white thrombus formation in the microminipig. N Miura
6 X 2012 Thromb Haemost 109(01),p102-111(2013) Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions. K Hosokawa
5 X 2012 Blood 120(18),p3812-3821(2012) Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf. Y Ono
4 X 2012 Haemophilia p1-7(2012) Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood. S Ogawa
3 X 2011 Microvasc Res 83,p154-161(2012) A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process. K Hosokawa
2 X 2011 Thromb Haemost 106(6),p1215-1223(2011) A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. S Ogawa
1 X 2011 J Thromb Haemost 9(10),p2029-2037(2011) A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. K Hosokawa
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.